In Brief
Norsworthy et al. discovered that forced expression of Sox11, a transcription factor expressed in differentiating retinal progenitors, is able to reactivate an axon growth program and promote axon regeneration in subsets of adult RGCs but kills other types, suggesting that this and similar reprogramming strategies may be more complex than previously appreciated.
INTRODUCTION
Neurons in the adult central nervous system (CNS) regenerate poorly after damage. Both extrinsic inhibitory factors and intrinsic constraints on growth in mature and injured neurons contribute to this regenerative failure. Recent studies have identified several methods that can activate growth-associated signaling pathways and promote neuronal survival and axon regeneration after injury (Bradke et al., 2012; He and Jin, 2016; Crair and Mason, 2016; Benowitz et al., 2017) . However, the regeneration effects observed to date are still limited. For example, the activation of mTOR by deleting Pten or overexpression of osteopontin (OPN; Spp1) and insulin-like growth factor (Igf1) promotes the selective regeneration of alpha retinal ganglion cells (a-RGCs) (Duan et al., 2015; Park et al., 2008) , which comprise only 6% of RGCs in intact retinas (Duan et al., 2015; Sanes and Masland, 2015) . Thus, new strategies are needed to promote regeneration of other types of RGCs.
We reasoned that manipulation of transcription factors that act as master controlling factors of axon growth during development might represent another avenue for promoting axon regeneration in adults. In fact, previous studies have shown that manipulations of Kr€ uppel-like family of transcription factors (KLFs) promoted axon regeneration (Moore et al., 2009 ). However, the observed regeneration phenotypes after KLF manipulations are relatively modest. A possible clue is that KLF expression changes significantly during the early postnatal period, coincident with dramatically decreasing axon growth ability in the neonatal age (Goldberg et al., 2002) . Thus, KLFs might maintain an axon growth program once it has been activated by other factors rather than initiating such a program. Based on this reasoning, we focused here on transcription factors that regulate the early differentiation of RGCs, during which axon growth is initiated (Livesey and Cepko, 2001; Mu and Klein, 2004) .
RESULTS

Identification of Sox11 as a Regeneration-Promoting Transcription Factor
We tested seven transcription factors for their ability to promote optic nerve regeneration. Genes were delivered by intravitreal injection of AAV serotype 2 vectors (AAV2) to mouse retinas; our previous work showed that this protocol leads to transduction of >90% of RGCs (Park et al., 2008; Nawabi et al., 2015) . As a control, we injected AAV-Plap (placental alkaline phosphatase, hereafter ''AAV-Control''), an unrelated protein with no detectable effect on retinal structure or regeneration (Nawabi et al., 2015; Bei et al., 2016) . Two weeks after virus injection, the optic nerve was crushed. After another 2 weeks, axon regeneration was monitored by an anterograde tracer fluorescent-conjugated cholera toxin subunit B (CTB).
Overexpression of Sox11 significantly increased regeneration of RGC axons (Figures 1A and 1C; Figures S1A and S1B) . Sox4 (a Sox11 homolog) and Brn3b ( Figures 1A-1C ) also increased axonal regeneration, but these effects did not reach statistical significance. The four other genes screened did not detectably increase regeneration ( Figures 1A-1C) . Interestingly, although some of these factors, such as Sox2, have been shown to be able to reprogram terminal differentiated fibroblasts into multipotent neuronal stem cells (Ring et al., 2012) , their overexpression failed to promote axon regeneration after injury. We therefore focused on Sox11 in subsequent studies.
In a separate experiment, we found that, at 4 weeks after injury, Sox11-induced axons frequently extended more than 4 mm past the crush site at this time ( Figures S1C and S1D ). However, Sox11 expression failed to increase neuronal survival and instead modestly decreased RGC survival (Figures 1D and 1E) , as revealed by immunostaining retinal sections with antibodies to the pan-RGC marker RBPMS (Rodriguez et al., 2014) . Thus, in contrast to other interventions, such as the deletion of Pten and/or Socs3, which increase both neuronal survival and axon regeneration (Park et al., 2008; Sun et al., 2011) , Sox11 overexpression promoted axon regeneration, but not survival.
Sox11
Kills a-RGCs and Promotes Axon Regeneration from Non-a-RGCs Recent studies have shown that some interventions, such as PTEN inhibition or co-expression of osteopontin and Igf1, selectively promote axon regeneration from a-RGCs (Duan et al., 2015) . We asked whether the same was true for Sox11. We marked a-RGCs with YFP using Kcng4-Cre mice crossed with reporter line Thy1-fl-STOP-fl-YFP (Duan et al., 2015) . We injected AAV-Control or AAV-Sox11 into the vitreous bodies of Kcng4-Cre; Thy1-fl-STOP-fl-YFP mice, performed optic nerve crush, and labeled all regenerating axons with CTB as described above. Although many regenerating CTB+ axons were found in Sox11-treated eyes, none of these were YFP positive (Figures 2A  and 2B ). In addition, we found a total absence of YFP+ fibers proximal to the crush site, whereas YFP+ fibers are evident in the control group (Figures 2A and 2B) . Moreover, few YFP-positive RGCs were present in Sox11-overexpressing retinas at 2 weeks after injury ( Figures 2C and 2D) .
The apparent absence of YFP-labeled a-RGCs could be explained either by the downregulation of their molecular markers (Yfp expression from the Thy1 locus) or by cell death. To distinguish between these possibilities, we used two additional markers. First, we used another reporter, Rosa26-CAGfl-STOP-fl-tdTomato, which expresses the fluorescent protein tdTomato under the control of a constitutive promoter (Madisen et al., 2010) . Second, we immunostained retinas with an endogenous marker of a-RGCs, osteopontin (Duan et al., 2015) . In AAV-Control-treated eyes, we confirmed the presence of a-RGCs through tdTomato expression coincident with osteopontin. In contrast, AAV-Sox11 led to the elimination of tdTomato+ or osteopontin+ RGCs, both in intact retinas and following nerve crush ( Figures 2E and 2F ). Thus, Sox11 expression likely induces the death of a-RGCs. This result implies that axons regenerating after Sox11 overexpression must arise from non-a-RGCs. In addition, we tested the effect of Sox11 in transgenic mice overexpressing Bcl2, a well-established antiapoptotic molecule that increases RGC survival after nerve crush (Bei et al., 2016; Bonfanti et al., 1996) . As expected, AAV-Sox11 improved regeneration over AAV-Control in the Bcl2 background ( Figure S2A ). However, the extent of Sox11-induced regeneration in Bcl2-overexpressing mice was not appreciably different from that observed in wild-type animals (compare Figure S2A to Figure 1C) . Further, even with Bcl2 co-treatment, Sox11 still failed to increase RGC survival ( Figure S2B ) and Bcl2 failed to rescue the Sox11-induced loss of Osteopontin+ a-RGCs ( Figure S2C ).
Intravitreally injected AAV2 vectors can transduce RGCs as well as other retinal cells (Park et al., 2008) . To determine whether Sox11 acts directly on RGCs to promote regeneration, we injected AAV2-FLEX-Sox11 into the vitreous bodies of Vglut2-Cre mice, in which Cre is expressed in RGCs selectively (Ellis et al., 2016) , and subjected these mice to an optic nerve injury. We found that AAV-FLEX-Sox11-induced regeneration was comparable to those induced by non-conditional AAV-Sox11 ( Figures S2D and S2E , as compared with Figures 1A and 1C) . Likewise, AAV-FLEX-Sox11 reduced pan-RGC survival to a degree essentially indistinguishable from non-specific AAV-Sox11 ( Figure S2F ) and was expressed well in surviving RGCs ( Figure S2G ). Thus, Sox11-induced axon regeneration is likely regulated in a cell-autonomous fashion. (B) Partial listing of Gene Ontology (GO) Biological Process terms. GO terms were generated separately for genes upregulated or downregulated (thresholded at FDR < 0.05) by AAV-Sox11 relative to AAV-Control. After Bonferroni correction, 57 terms were significantly enriched in upregulated transcripts and 144 in downregulated transcripts. This panel shows the 20 GO terms with the largest sum of fold enrichment from up-and down-lists, then sorts the terms by direction of enrichment. Numbers in black indicate the overall number of genes in the GO term definition; numbers in blue and red indicate the number of differentially expressed genes at FDR < 0.05 that are listed in the given GO term definition. Bars indicate the fold enrichment over the number of genes expected to appear if genes were randomly selected. Asterisks indicate significance of GO term enrichment: *p < 0.05; **p < 0.01; ***p < 0.001. The full list of significant GO terms is provided in Table S2 , alongside the enrichment scores and p values.
(legend continued on next page)
Developmental Axon Growth Programs Activated by Sox11 in Adult RGCs
To gain mechanistic insights into the effects of Sox11, we performed gene expression profiling analysis in RGCs. To this end, we injected AAV-Sox11 or AAV-Control into the vitreous bodies of wild-type mice, waited 2 weeks, and performed optic nerve injury. Three days later, we dissociated RGCs, labeled them with antibodies against the RGC-selective marker THY1, and purified them by fluorescence-activated cell sorting (FACS) ( Figure 3A ). By immunostaining, we verified the presence of a-RGCs in the samples prepared from both AAV-Control-and AAV-Sox11-treated retinas at this time point (Figures S3A and S3B) . Messenger RNAs from the purified cells were then used for library preparation and sequencing ( Figure 3A ; Figure S3C ). From 26,691 annotated transcripts, we identified 2,797 differentially expressed (DE) genes at the threshold of FDR < 0.1 (Figures S3D and S3E; Table S1 ). Gene ontology (GO) analysis showed that two groups of similar GO terms account for a large fraction of the upregulated transcripts ( Figure 3B ; Table S2 ). The first group is related to the biosynthesis and metabolism of ceramide ( Figure 3B ). In light of evidence for a role of the ceramide-sphingolipid in cell death (Mencarelli and Martinez-Martinez, 2013) , these results might point to a possible mechanistic link to Sox11-triggered death of a-RGCs. The second group includes axon growth-related cellular functions, such as cell-cell adhesion, cell morphogenesis involved in differentiation, neuron process development, and axonogenesis ( Figure 3B ), suggesting that Sox11 is able to re-activate axon growth programs. On the other hand, the majority of genes downregulated by Sox11 were associated with synaptic transmission ( Figure 3B ). As previous studies showed that, during development, axonal growth loss is associated with the switching from an axon growth mode in embryonic stages to the synapse growth mode in mature stages (Goldberg et al., 2002; Enes et al., 2010) , these results support the model that Sox11 overexpression reprogram adult RGCs into an immature stage.
In further support of the notion that Sox11 activates an axon growth program, we found that, among the most significantly altered genes ( Figure 3C ), several are cytoskeletal regulators: for example, doublecortin (Dcx) (Gleeson et al., 1999; Schaar et al., 2004) , microtubule-associated protein 1B (Map1b) (Hammarback et al., 1991; Opal et al., 2003) , Ras GTPase-activating-like protein Iqgap1 (Hart et al., 1996) , and Rho Guanine Nucleotide Exchange Factor 26 (Arhgef26) (Samson et al., 2013) . Dcx was of particular interest because it is crucial for axon growth and neuronal migration during development (Gleeson et al., 1999; Schaar et al., 2004) ; it is expressed by newly differentiated neurons and then quickly downregulated during neuronal maturation (Gleeson et al., 1999) . Moreover, we recently showed that overexpression of Dcx promotes optic nerve regeneration (Nawabi et al., 2015) . We therefore used immunostaining with anti-DCX antibodies to validate the effect of Sox11 on Dcx expression. As expected, DCX staining was barely detectable in RGC cell bodies from control uninjured eyes, but Sox11 overexpression increased DCX staining of RGCs in both intact retina and following optic nerve crush (Figure 3D) . These results support the idea that Sox11 promotes axon regeneration by activating the axon growth program used during development.
Pten Deletion Further Enhances the RegenerationPromoting Effects of Sox11 from Non-a-RGCs Previous studies showed that Pten dramatically enhances survival of RGCs and selectively promotes regeneration of a-RGCs (Park et al., 2008; Duan et al., 2015) . In contrast, results presented above show that Sox11 leads to death of a-RGCs and promotes regeneration of non-a-RGCs. These distinct effects led us to explore the functional interaction of Sox11 and Pten deletion. In Pten f/f mice, we deleted Pten using AAV-Cre mixed with either AAV-Control (hereafter ''DPten/Control'') or AAVSox11 (hereafter ''DPten/Sox11''). Optic nerves were injured 2 weeks later, and axon regeneration was analyzed by CTB tracing 2 or 7 weeks after injury. (Figure 1 ). By 7 weeks after injury, many regenerating axons were observed in the optic tract after crossing the chiasm ( Figures 4A-4C ); this length of regeneration was seldom observed in mice following either Sox11 expression or Pten deletion alone. Notably, as in wild-type mice, Sox11 decreased the survival of RBPMS+ RGCs in PTEN-deleted mice (Figures 1 and 4D ). The number of SOX11-expressing RGCs and the intensity of the expression were moderately increased in Pten-deleted retinas as compared with Pten-preserved ones, when all retinas were treated with AAV-Sox11. We next wanted to distinguish whether regeneration induced by DPten/Sox11 acted upon a-or non-a-RGCs and whether Sox11-regulated mechanisms were conserved in DPten/Sox11-regenerating RGCs. Thus, we developed a protocol to retrogradely label RGCs with regenerating axons by injecting the tracer Fluoro-Gold in the distal optic nerve and then analyzed Fluoro-Gold-positive RGCs in the retinal sections. With this protocol, many RGCs were labeled in intact wild-type mice, but none of RGCs were labeled in the mice after injury ( Figure S4C ). In the DPten/Control group, FluoroGold-positive RGCs were observed across the retina sections. Consistent with previous results (Duan et al., 2015) , the majority of these individually examined RGCs (over 200 cells) were a-RGCs as they were co-stained with the a-RGC marker OPN as well as a second a-RGC marker SMI32 ( Figures 4G  and 4H ).
In the DPten/Sox11 group, many RGCs were also labeled with Fluoro-Gold ( Figure 4E ). All these Fluoro-Gold-positive RGCs expressed the RGC markers RBPMS and class III b tubulin or TUJ1 (Figures 4E and 4F ), but none were from a-RGCs (Figures 4G and 4H) . In fact, few OPN-or SMI32-positive RGCs were observed in all DPten/Sox11-treated retinas, suggesting a near-total loss of a-RGCs ( Figure S4F ). Finally, as expected, many of these Fluoro-Gold-labeled RGCs also expressed DCX ( Figure S4D ), a young neuron marker upregulated by Sox11 alone (Figures 3C and 3E) , and phospho-S6 ( Figure S4E ), an mTOR-activity indicator upregulated by Pten deletion (Park et al., 2008) . Together, our results indicate that Pten deletion could further enhance axonal regeneration from non-a-RGCs induced by Sox11 overexpression.
DISCUSSION
Repurposing Developmental Programs for Regeneration
Multiple factors have been shown to be key in the differentiation of RGCs during development (Livesey and Cepko, 2001; Mu and Klein, 2004) . However, it remains unclear which factors are most relevant to the axon growth program. Our results suggest that Sox11 is one such critical factor. Both Sox11 and Sox4 are members of the Sry-related high-mobility group (HMG) box (Sox) family of transcription factors that have been implicated as critical regulators of cell fate, differentiation, and survival during development (Sarkar and Hochedlinger, 2013; Chang et al., 2017; Kuwajima et al., 2017) . Sox11 promoted strong and significant axonal regeneration, and Sox4 likely promoted regeneration albeit with marginal significance. These results are consistent with the notion that Sox4 and Sox11 have redundant biological effects (Jiang et al., 2013) . Previous studies have also implicated Sox11 in promoting regeneration of the peripheral nervous system (PNS) (Jing et al., 2012; Jankowski et al., 2009; Chandran et al., 2016) and corticospinal axons . Gene profiling showed that Sox11 activates a set of developmental axon growth-related genes in RGCs, consistent with the possibility that it is a master regulator of the axonal growth program. Sox11 also downregulates genes involved in synaptic transmission and related functions, consistent with previous observations on the development-dependent switching from axon growth mode immature neurons to dendrite/synapse growth mode in mature neurons (Goldberg et al., 2002; Enes et al., 2010) . However, it remains to be determined whether the inhibition of dendrite/synapse function is required for Sox11-mediated activation of axon growth program.
Along with its beneficial effect on promoting axon regeneration, Sox11 expression had the distressing effect of leading to the death of nearly all a-RGCs. In this regard, our gene profiling studies indeed revealed that Sox11 overexpression could upregulate the biosynthesis and metabolism of ceramide, a critical regulator of neuronal stress response and cell death (Mencarelli and Martinez-Martinez, 2013 ). In addition, Welsbie et al. (2017) show that Sox11 is involved in Dlk/Mapk-mediated RGC death. Furthermore, a previous study showed that, despite promoting some CST regrowth, Sox11 overexpression resulted in worsening of motor performance outcomes Jayaprakash et al., 2016) ; we speculate that Sox11-mediated cell death might have contributed to such behavioral impairments. On the other hand, it has been shown that, during development, Sox11 and Sox4 are critical for preventing the death of RGC (Jiang et al., 2013) , sympathetic (Potzner et al., 2010) , and DRG neurons (Lin et al., 2011) . How Sox11 shows such differential survival effects on different neuronal types remains unclear. Any attempts to use Sox11 or other reprogramming methods as neural repair strategies (Li and Chen, 2016) will need to take account of these double-edged effects.
Neuronal Subtype-Specific Control of Axon Regeneration
Our recent studies showed that Pten deletion or overexpression of osteopontin and Igf1 selectively promotes the axon regeneration from a-RGCs (Duan et al., 2015) . In view of this result, it was surprising that Sox11 expression both promoted axon regeneration and killed virtually all a-RGCs. The implication, which we supported by retrograde labeling from regenerating axons, is that Sox11 promotes regeneration of RGC types that are refractory to the effects of mTOR activation. Moreover, even in combination with mTOR activation (Pten deletion), Sox11 kills a-RGCs and promotes regeneration from nona-RGCs. There are at least 30 RGC types in mouse, each with distinct morphological, molecular, and functional properties (Sanes and Masland, 2015; Baden et al., 2016) . It will be challenging to identify which RGC types are affected by Sox11, but the availability of increasing numbers of markers and transgenic lines (Sanes and Masland, 2015; Dhande and Huberman, 2014) provides a means of addressing this issue.
These results provide new evidence for the idea that distinct neuron types differ in their regenerative responses to certain manipulations (He and Jin, 2016). The presence of resilient and susceptible populations of RGCs is particularly intriguing in this regard because most RGCs are similar in many respects: their somata are in the ganglion cell layer, their dendrites arborize in the inner plexiform layer, their axons run through the optic nerve to the brain, they are glutamatergic, and they express markers such as RBPMS, THY1, and BRN3 class transcription factors. These similarities, then, make the remaining differences between RGC types all the more compelling. By comparing RGC types before and after injury, and following interventions such as Sox11 or Pten deletion, it should be possible to identify the critical factors required for survival or regeneration following injury. 
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EXPERIMENTAL MODELS Mouse Lines
Mouse lines including Kcng4-Cre and Thy1-fl-STOP-fl-YFP were generated and characterized in our laboratories (Duan et al., 2015) . Kcng4-Cre was crossed with Thy1-fl-STOP-fl-YFP or Rosa26-CAG-fl-STOP-fl-tdTomato (Jackson Laboratory) to label a-RGCs. Wild-type mice were purchased from Charles River Laboratories. Bcl2 mouse line was described previously (Bei et al., 2016) . Vglut2-Cre mice were obtained from Jackson Laboratory (016963). In experiments where a transgenic mouse line was not specified, mixed-background wild-types were used.
Mouse Husbandry
All experiments were performed in compliance with protocols approved by the IACUC at Boston Children's Hospital. Mice were given ad libitum access to food and water, and housed in cages under positive-pressure filtered air supplies with bedding changed frequently. Mice were not permitted to breed before or during their inclusion in in vivo experiments.
METHOD DETAILS In Vivo Procedures and Reagents
Production of AAVs Vectors of AAV-Pax6 and AAV-Isl1 were made by inserting mouse Pax6 cDNA (Addgene #32932) and mouse Isl1 cDNA (Addgene #32929) respectively into an AAV plasmid consisting of the cytomegalovirus enhancer fused to the chicken beta-actin promoter (CAG promoter) and Woodchuck hepatitis virus Posttranscriptional Regulatory Element (Wpre). The other vectors were assembled similarly, with coding sequences either cloned in-house from cDNAs or directly chemically synthesized. All pAAVs, as listed in the Key Resources Table, were then packaged into AAVs of serotype 2/2 (titers: > 5 3 10 12 genome copies per milliliter) by the Boston Children's Hospital Viral Core.
Intravitreal Injection and Optic Nerve Crush
For intravitreal injection, adult animals were anesthetized with ketamine/xylazine (100/10 mg/kg) and then AAV (1-3 ml) or Alexaconjugated cholera toxin beta subunit (CTB-555, 1 mg/ml; 1-2 ml) was injected intravitreally with a fine glass pipette attached to the Hamilton syringe using plastic tubing. CTB-555 injection was performed 2-3 days before euthanasia to trace regenerating RGC axons. For optic nerve crush in anesthetized animals, the optic nerve was accessed intraorbitally and crushed using a pair of Dumont #5 forceps (FST), two weeks after AAV injection. More detailed surgical methods were described by Park et al. (2008) and Bei et al. (2016) .
Retrograde Tracing of RGCs
Two weeks after optic nerve crush, a cranial opening was created over the frontal cortex and a distal segment of the crushed optic nerve was exposed intracranially through removing overlying brain tissues. 4% Fluoro-Gold (Fluorochrome) was slowly injected into the optic nerve approximately 1-1.5 mm distal to the crush site using a fine glass pipette. Care was taken to minimize passive diffusion of Fluoro-Gold solution back toward the crush site including removing overflowing Fluoro-Gold solution.
Histology
Tissue Preparation
Anesthetized animals were transcardially perfused with 4% paraformaldehyde (PFA). Dissected optic nerves, brains, and eyeballs were post-fixed in 4% PFA overnight, and then immersed in sucrose solutions at least two days before embedding and snap-freezing in OCT. Sucrose solutions contained 15% sucrose in PBS for optic nerves, or 30% sucrose in PBS for eyes and brains. Typically, 10-14 mm thick sections were cut for optic nerves, 16-20 mm thick sections for retinas and 25 mm thick sections for mouse brains. Sections were adhered to room-temperature charged microscope slides, dried, and frozen until further processing. Slides were then either washed and mounted for imaging with an anti-fade reagent, for example, for some CTB-traced optic nerves, or further processed for immunohistochemistry. Some retinas were dissected out in toto after post-fixing in PFA, washed with PBS, immunostained, cut radially with scissors to flatten the tissue, and then mounted for imaging.
Staining Conditions
For immunohistochemistry, whole mount retinas were generally blocked for one hour in PBS with 5% donkey serum and 0.3% Triton X-100, and then incubated 0.5-2 days at 4 C in primary antibodies diluted in PBS with 3% donkey serum and 0.3% Triton X-100, followed by treatment of secondary antibodies (Jackson ImmunoResearch or Invitrogen) for 1-2 hr at room temperature after rinsing. Immunohistochemistry on sections was performed generally by blocking with 3% bovine serum albumin and 0.5% Triton X-100 in PBS, incubation with primary antibodies overnight at 4 C in blocking solution, then incubation with secondary antibodies for 2 hr at room temperature. Antibodies Primary antibodies used were: Goat anti-DCX (1:400, Santa Cruz sc8066); chicken anti-GFP (1:1000, Abcam ab13970); rabbit anti-RFP (1:500, Abcam ab34771); goat anti-Osteopontin (1:1000, R&D Systems AF808); rabbit anti-phosphorylated S6 Ser235/236 (1:200, Cell Signaling 4857); rabbit anti-RBPMS (1:500, Abcam ab194213); guinea pig anti-RBPMS (P4-P24) (1:2000, Raygene custom order A008712 to peptide GGKAEKENTPSEANLQEEEVRC); mouse anti-SMI32 (1:1000, BioLegend/Covance SMI-32R); goat anti-Sox11 C-20 (1:200, Santa Cruz sc17347); mouse anti-TUJ1 (1:400, BioLegend 801202); rabbit anti-Tubb3 (1:400, Abcam ab18207). Fluorescent secondary antibodies used were generally from either Invitrogen/Thermo-Fisher Scientific or Jackson ImmunoResearch, raised in either goat or donkey against the primary antibody's host species, and conjugated to fluorophores of DyLight 405; Alexa Fluor 488; Cy3; or Alexa Fluor 647 as appropriate, and generally used at 1:800 final dilution. Microscopy For nerve sections and some whole-mount retinas, individual fluorescent images were acquired using Ultraview Vox Spinning Disk Confocal Microscope (Perkin Elmer) and automatically stitched using Volocity software (Perkin Elmer). For some retina sections, images were taken using epi-fluorescent microscopy with a Nikon TiE Eclipse epifluorescent microscope with automated tiling or Zeiss LSM 700 fluorescent confocal microscopy. Z stacks were projected onto a single plane using either Volocity or ImageJ. Brightness and contrast of the images were adjusted and pseudo-colors applied for presentation. When imaging was taken for quantification, image capture and processing were kept constant.
Experimental Design Inclusion and Exclusion Criteria
The vast majority of samples in all experiments were included in their respective final datasets. However, occasionally samples were rejected as follows: (1) At the time of sacrifice and dissection, eyes were rejected if lens injury or hardening of the vitreous humor was apparent. This generally resulted in rejection of zero to one retinas and/or optic nerves per experiment. (2) During sample preparation, a minority of samples were damaged from human error, such as cryosectioning severely orthogonal to the intended plane of sectioning, and excluded from further analysis. (3) Microscopy images of retinal or optic nerve sections were excluded if sectioning was orthogonal, similar to criteria 2 above. (4) Once experiments entered statistical analysis, no further samples were excluded by any formal or informal criterion.
Randomization and Efforts to Minimize Systematic Errors
Experiments involving mice included both adult males and females, generally between the ages of 6 to 10 weeks, and control and treatment groups were always balanced for female:male ratios, ages, different litters, and/or background as applicable.
Experimental design for histological samples involving surgeries, i.e., injections and nerve crushes, were always carefully balanced for possible unilateral-specific artifacts caused by the surgeon. More specifically, experiments always used one of two strategies: (1) using only one retina and nerve (e.g., the right eye) per mouse, for all treatment groups, or (2) using an equal 50:50 balance of left and right eyes for both treatment groups. Blinding Generally, phenotypes were sufficiently obvious and reproducible in the hands of multiple authors that blinding was judged unnecessary for analysis. However, during the initial screens that identified Sox11, blinding was used for our first characterizations of pan-RGC survival. Additionally, for some histological analysis of retinas involving Pten/Sox11, the results from non-blinded quantifications were repeated by a second investigator who was blinded. In such cases, the second investigator's conclusions would be considered final.
RNA-Seq Preparation
RGC Enrichment and RNA Isolation
Retinas were dissected, dissociated in serum-free media using papain, triturated carefully, then stained with Thy1.2-PE-Cy7 antibody (Affymetrix eBioscience 25-0902-82) and SYTOX live-dead cell stain, then flow sorted on a BD FACS Aria II using an 85 micron nozzle to a goal of approximately 100,000 events. Using the Arcturus PicoPure kit, RGCs identified by FACS were sorted directly into extraction buffer XB and lysed immediately after sorting according to the kit's instructions. RNA quality was verified with an Agilent BioAnalyzer 2100. All experimental steps through RNA extraction were performed in triplicate for the control and experimental group, with each replicate performed a different day. The samples within a replicate were prepared on the same day, in a different order each replicate, to avoid any systemic errors from differences in timing. Sequencing Reactions RNA-sequencing was carried out for the RNAs with by the UCLA Neuroscience Genomics Core. Briefly, cDNA was generated using the Ovation RNA-Seq System V2 kit (NuGEN), followed by library preparation using the TruSeq Nano DNA Library Prep kit (Illumina). Samples were sequenced using an Illumina HiSeq-4000 sequencer with 69-base paired end reads resulting in a minimum of 50M reads per sample.
QUANTIFICATION AND STATISTICAL ANALYSIS Quantifications Involving Regenerating Axons
For quantifying regeneration of axons traced with fluorescent CTB, we took longitudinal sections of optic nerves and counted the total number of CTB+ axons at multiple distances along the optic nerve, anterograde from the crush site. The counts were transformed to a density of axons, then multiplied by the nerve's approximate cross-sectional area to estimate the total number of axons in each respective nerve. More specifically, we used four sections from each nerve to estimate that nerve's axon count, and took each estimate as a single biological sample for subsequent statistical testing. For quantification of fluorescent protein co-localization with regenerating axons in optic nerves, axons were counted with their number estimated according to a method described previously (Bei et al., 2016) . In analyzing YFP-positive axons, care was taken to exclude fluorescent signals from tissue debris. We confirmed that axon regeneration counts, at several distances from the crush site, followed an approximately normal distribution by the Kolmogorov-Smirnov test (p > 0.1).
